You are here

tanezumab

Eli Lilly and Pfizer Put Osteoarthritis Pain Drug Out of its Misery

BioSpace

Wed, 10/27/21 - 11:38 pm

FDA Advisory Committee Raises Objections to Pfizer and Eli Lilly’s Tanezumab

BioSpace

Thu, 03/25/21 - 10:47 pm

advisory panels

Pfizer has run 41 trials over 15 years for tanezumab. As adcomm nears, the FDA remains unimpressed — and more than a little worried

Endpoints

Mon, 03/22/21 - 10:42 am

advisory panels

Pfizer-Lilly Endeavor Shows NGF Inhibitor Tanezumab Lowers Osteoarthritic Pain

BioSpace

Thu, 10/8/20 - 11:29 pm

FDA starts review of Pfizer, Lilly’s non-opioid painkiller

Pharmaforum

Tue, 03/3/20 - 10:49 am

non-opioid pain treatments

After painting a poor safety profile, Pfizer and Eli Lilly are shooting for a new pain drug OK anyway

Endpoints

Mon, 07/29/19 - 09:30 am

Safety setback for Pfizer, Lilly pain drug should have Regeneron and Teva feeling nervous

Biopharma Dive

Mon, 04/22/19 - 03:37 pm

Teva Pharmaceutical

Pfizer, Lilly to mull anti-NGF mAb's future after joint safety events spike in long-term readout

BioCentury

Fri, 04/19/19 - 05:57 pm

Lower dose of Pfizer-Lilly painkiller misses main goals in late stage study

Yahoo/Reuters

Thu, 04/18/19 - 10:35 pm

clinical trials

osteoarthritis of the knee

R&D round-up: Non-opioid painkiller space heats up

Pharmaforum

Sat, 03/16/19 - 12:38 pm

non-opioid pain treatments

Kings College London

Higher dose of Pfizer-Lilly drug helps reduce back pain in study

Yahoo/Reuters

Tue, 02/19/19 - 09:54 am

chronic low back pain

clinical trials

opioid alternatives

Pfizer and Lilly’s tanezumab succeeds in second phase 3 osteoarthritis pain trial

Pharmaceutical Business Review

Wed, 01/30/19 - 10:05 am

clinical trials

osteoarthritis pain

Does Pfizer Have A Multibillion-Dollar Replacement For Opioids?

Investors Business Daily

Mon, 12/31/18 - 12:15 pm

Tanezumab's Phase 3 Results: A Promising Sign For Non-Opioid Pain Treatments

Forbes

Thu, 09/6/18 - 09:44 am

pain management

clinical trials

Eli Lilly, Pfizer celebrate a PhIII success for their blockbuster pain drug contender tanezumab — but questions linger

Endpoints

Wed, 07/18/18 - 09:51 am

Lilly's bet on pain stands out amid bare pharma pipeline

Biopharma Dive

Mon, 03/26/18 - 09:58 pm

Lilly says new type of pain drug could lessen need for opioids

Yahoo/Reuters

Tue, 05/24/16 - 11:40 pm

Pfizer Steps Out Of Johnson & Johnson's Shadow To Get A Tan

Seeking Alpha

Mon, 04/11/16 - 05:20 pm

Pfizer, Lilly to resume late-stage study testing pain drug

Yahoo/Reuters

Mon, 03/23/15 - 11:28 am

Pfizer, Lilly Vs. Rivals In Potential Pain Drug Rivalry

Seeking Alpha

Wed, 11/13/13 - 08:32 am

Pages